HomeSCPI • IDX
add
Organon Pharma Indonesia Tbk PT
Market news
Financials
Income Statement
Revenue
Net income
(IDR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 507.30B | -14.81% |
Operating expense | 26.96B | 68.66% |
Net income | -73.82B | -193.25% |
Net profit margin | -14.55 | -243.97% |
Earnings per share | — | — |
EBITDA | -77.63B | -215.82% |
Effective tax rate | 19.40% | — |
Balance Sheet
Total assets
Total liabilities
(IDR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 123.15B | -24.95% |
Total assets | 1.42T | 4.40% |
Total liabilities | 580.90B | 54.46% |
Total equity | 840.45B | — |
Shares outstanding | 3.60M | — |
Price to book | 0.12 | — |
Return on assets | -16.19% | — |
Return on capital | -24.97% | — |
Cash Flow
Net change in cash
(IDR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -73.82B | -193.25% |
Cash from operations | 85.01B | -67.50% |
Cash from investing | -19.74B | -614.29% |
Cash from financing | -149.65B | 6.26% |
Net change in cash | -84.53B | -184.59% |
Free cash flow | 64.42B | 565.08% |
About
Founded
1972
Website
Employees
199